[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Live Attenuated Vaccines Market Research Report 2021

August 2016 | 105 pages | ID: G783F4749DFEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Live Attenuated Vaccines

Revenue, means the sales value of Live Attenuated Vaccines

This report studies Live Attenuated Vaccines in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
  • Astellas Pharma Inc
  • CSL Limited
  • Emergent BioSolutions, Inc
  • GlaxoSmithKline
  • Johnson & Johnson
  • MedImmune, LLC
  • Merck & Co
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute
  • India Pvt. Ltd. (India)
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Live Attenuated Vaccines in these regions, from 2011 to 2021 (forecast), like
  • North America
  • China
  • Europe
  • Japan
  • India
  • Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Pneumococcal
  • Influenza
  • HPV
  • Hepatitis
  • Rotavirus
  • DTP
  • Polio
  • MMR
Split by application, this report focuses on sales, market share and growth rate of Live Attenuated Vaccines in each application, can be divided into
  • Pediatric
  • Adult
  • Application 3
Global Live Attenuated Vaccines Market Research Report 2021

1 LIVE ATTENUATED VACCINES OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Live Attenuated Vaccines Segment by Types
  1.2.1 Global Sales Market Share of Live Attenuated Vaccines by Type in 2015
  1.2.2 Pneumococcal
  1.2.3 Influenza
  1.2.4 HPV
  1.2.5 Hepatitis
  1.2.6 Rotavirus
  1.2.7 DTP
  1.2.8 Polio
  1.2.9 MMR
1.3 Live Attenuated Vaccines Segment by Applications
  1.3.1 Pediatric
  1.3.2 Adult
  1.3.3 Application
1.4 Live Attenuated Vaccines Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Live Attenuated Vaccines (2011-2021)
  1.5.1 Global Live Attenuated Vaccines Sales and Revenue (2011-2021)
  1.5.2 Global Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
  1.5.3 Global Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)

2 GLOBAL LIVE ATTENUATED VACCINES MARKET COMPETITION BY MANUFACTURERS

2.1 Global Live Attenuated Vaccines Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Live Attenuated Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Live Attenuated Vaccines Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL LIVE ATTENUATED VACCINES ANALYSIS BY REGION

3.1 Global Live Attenuated Vaccines Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Live Attenuated Vaccines Sales Market Share by Region (2011-2021)
  3.1.2 Global Live Attenuated Vaccines Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
  3.2.2 North America Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
  3.4.2 China Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
  3.6.2 India Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL LIVE ATTENUATED VACCINES ANALYSIS BY TYPE

4.1 Global Live Attenuated Vaccines Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Live Attenuated Vaccines Sales and Market Share by Type (2011-2021)
  4.1.2 Global Live Attenuated Vaccines Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Pneumococcal Sales, Revenue, Price and Growth (2011-2021)
4.3 Influenza Sales, Revenue, Price and Growth (2011-2021)
4.4 HPV Sales, Revenue, Price and Growth (2011-2021)
4.5 Hepatitis Sales, Revenue, Price and Growth (2011-2021)
4.6 Rotavirus Sales, Revenue, Price and Growth (2011-2021)
4.7 DTP Sales, Revenue, Price and Growth (2011-2021)
4.8 Polio Sales, Revenue, Price and Growth (2011-2021)
4.9 MMR Sales, Revenue, Price and Growth (2011-2021)

5 GLOBAL LIVE ATTENUATED VACCINES MARKET ANALYSIS BY APPLICATION

5.1 Global Live Attenuated Vaccines Sales and Market Share by Application (2011-2021)
5.2 Major Regions Live Attenuated Vaccines Sales by Application in 2015 and 2016
  5.2.1 North America Live Attenuated Vaccines Sales by Application
  5.2.2 Europe Live Attenuated Vaccines Sales by Application
  5.2.3 China Live Attenuated Vaccines Sales by Application
  5.2.4 Japan Live Attenuated Vaccines Sales by Application
  5.2.5 India Live Attenuated Vaccines Sales by Application
  5.2.6 Southeast Asia Live Attenuated Vaccines Sales by Application

6 GLOBAL LIVE ATTENUATED VACCINES MANUFACTURERS ANALYSIS

6.1 Astellas Pharma Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Live Attenuated Vaccines Product Overview
    6.1.2.1 Pneumococcal
    6.1.2.2 Influenza
    6.1.2.3 HPV
  6.1.3 Live Attenuated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
6.2 CSL Limited
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Live Attenuated Vaccines Product Overview
    6.2.2.1 Pneumococcal
    6.2.2.2 Influenza
    6.2.2.3 HPV
  6.2.3 Live Attenuated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
6.3 Emergent BioSolutions, Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Live Attenuated Vaccines Product Overview
    6.3.2.1 Pneumococcal
    6.3.2.2 Influenza
    6.3.2.3 HPV
  6.3.3 Live Attenuated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
6.4 GlaxoSmithKline
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Live Attenuated Vaccines Product Overview
    6.4.2.1 Pneumococcal
    6.4.2.2 Influenza
  6.4.3 Live Attenuated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
6.5 Johnson & Johnson
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Live Attenuated Vaccines Product Overview
    6.5.2.1 Pneumococcal
    6.5.2.2 Influenza
  6.5.3 Live Attenuated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
6.6 MedImmune, LLC
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Live Attenuated Vaccines Product Overview
    6.6.2.1 Pneumococcal
    6.6.2.2 Influenza
  6.6.3 Live Attenuated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
6.7 Merck & Co
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Live Attenuated Vaccines Product Overview
    6.7.2.1 Pneumococcal
    6.7.2.2 Influenza
  6.7.3 Live Attenuated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
6.8 Pfizer
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Live Attenuated Vaccines Product Overview
    6.8.2.1 Pneumococcal
    6.8.2.2 Influenza
  6.8.3 Live Attenuated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
6.9 Sanofi Pasteur
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Live Attenuated Vaccines Product Overview
    6.9.2.1 Pneumococcal
    6.9.2.2 Influenza
  6.9.3 Live Attenuated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
6.10 Serum Institute
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Live Attenuated Vaccines Product Overview
    6.10.2.1 Pneumococcal
    6.10.2.2 Influenza
  6.10.3 Live Attenuated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
6.11 India Pvt. Ltd. (India)

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Live Attenuated Vaccines
Figure Global Sales Market Share of Live Attenuated Vaccines by Type in 2015
Table Live Attenuated Vaccines Product Type of by Manufacturers
Table Live Attenuated Vaccines Sales Market Share by Application in 2015 and 2016
Figure North America Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure China Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure India Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales and Revenue (2011-2021)
Figure Global Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure Global Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Global Live Attenuated Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Live Attenuated Vaccines Sales Share by Manufacturers
Figure 2016 Live Attenuated Vaccines Sales Share by Manufacturers
Table Global Live Attenuated Vaccines Revenue by Manufacturers (2015 and 2016)
Table Global Live Attenuated Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Live Attenuated Vaccines Revenue Share by Manufacturers
Table 2016 Global Live Attenuated Vaccines Revenue Share by Manufacturers
Table Manufacturers Live Attenuated Vaccines Manufacturing Base Distribution and Product Type
Table Global Live Attenuated Vaccines Sales Market by Region (2011-2021)
Figure Global Live Attenuated Vaccines Sales Market by Region (2011-2021)
Figure Global Live Attenuated Vaccines Sales Market Share by Region (2011-2021)
Table Global Live Attenuated Vaccines Revenue Market by Region (2011-2021)
Table Global Live Attenuated Vaccines Revenue Market Share by Region (2011-2021)
Table North America Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure North America Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Europe Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure Europe Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table China Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure China Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Japan Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure Japan Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table India Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure India Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales by Type (2011-2021)
Table Global Live Attenuated Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Live Attenuated Vaccines by Type (2011-2021)
Figure Global Live Attenuated Vaccines Sales Growth Rate by Type (2011-2021)
Table Global Live Attenuated Vaccines Revenue by Type (2011-2021)
Table Global Live Attenuated Vaccines Revenue Share by Type (2011-2021)
Figure Global Live Attenuated Vaccines Revenue Growth Rate by Type (2011-2021)
Figure Pneumococcal Sales, Revenue and Growth (2011-2021)
Figure Pneumococcal Price Trend (2011-2021)
Figure Influenza Sales, Revenue and Growth (2011-2021)
Figure Influenza Price Trend (2011-2021)
Figure HPV Sales, Revenue and Growth (2011-2021)
Figure HPV Price Trend (2011-2021)
Figure Hepatitis Sales, Revenue and Growth (2011-2021)
Figure Hepatitis Price Trend (2011-2021)
Figure Rotavirus Sales, Revenue and Growth (2011-2021)
Figure Rotavirus Price Trend (2011-2021)
Figure DTP Sales, Revenue and Growth (2011-2021)
Figure DTP Price Trend (2011-2021)
Figure Polio Sales, Revenue and Growth (2011-2021)
Figure Polio Price Trend (2011-2021)
Figure MMR Sales, Revenue and Growth (2011-2021)
Figure MMR Price Trend (2011-2021)
Table Global Live Attenuated Vaccines Sales by Application (2011-2021)
Table Global Live Attenuated Vaccines Sales Market Share by Application (2011-2021)
Figure Global Live Attenuated Vaccines Sales Market Share by Application in 2015
Figure Global Live Attenuated Vaccines Sales Market Share by Application in 2021
Table North America Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Europe Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table China Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Japan Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table India Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Southeast Asia Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Global Live Attenuated Vaccines Sales Growth Rate by Application (2011-2021)
Figure Global Live Attenuated Vaccines Sales Growth Rate by Application (2011-2021)
Table Astellas Pharma Inc Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories